Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: DIAGNOS Inc.

Market Cap 28M 19.75M 17.22M 15.95M 14.93M 1.86B 28.17M 189M 73.32M 917M 74.12M 72.54M 3.18B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 27.47M 19.38M 16.89M 15.65M 14.65M 1.83B 27.64M 186M 71.94M 900M 72.73M 71.17M 3.12B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
88.96%
Yield 2025 *
-
Yield 2026 -
1 day-5.38%
1 week+12.82%
Current month-4.35%
1 month+18.92%
3 months-18.52%
6 months-37.14%
Current year-41.33%
1 week 0.19
Extreme 0.19
0.25
1 month 0.18
Extreme 0.18
0.3
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.6
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2008-04-30
Chief Operating Officer - 2024-01-15
Director TitleAgeSince
Director/Board Member - 2000-09-20
Director/Board Member 72 2020-09-27
Chairman 69 2025-10-29
Date Insider Type Main position Quantity % Market Cap.
06-10Option

Chief Financial Officer

200,000 0.1661%
06-10Option

Chairman

300,000 0.2491%
06-10Option

Director

250,000 0.2076%
Change 5-day change 1-year change 3-year change Capi.($)
-5.38%+12.82%+10.00%-40.54% 19.75M
-0.72%-7.69%-14.22%+89.11% 234B
+0.13%-1.58%-37.30%-34.30% 81.48B
+0.50%-3.77%+8.42%+29.73% 80.51B
-3.85%-25.27%-58.11%-59.78% 78.32B
-1.16%-3.83%-39.97%-9.20% 55.4B
+1.33%-6.12%-32.74%-16.87% 45.09B
-0.72%-2.21%-4.58%+70.48% 34.54B
-0.11%+1.00%-33.62%-2.83% 32.45B
-0.11%-2.47%-6.06%+172.00% 30.89B
Average -1.01%-3.49%-20.82%+19.78% 67.28B
Weighted average by Cap. -0.66%-7.51%-22.84%+32.94%

Financials

2025 2026
Net sales 104K 73.21K 63.84K 59.12K 55.35K 6.91M 104K 701K 272K 3.4M 275K 269K 11.81M 65.48K 46.19K 40.27K 37.3K 34.91K 4.36M 65.87K 442K 171K 2.15M 173K 170K 7.45M
Net income -4.29M -3.02M -2.64M -2.44M -2.29M -285M -4.31M -28.96M -11.23M -140M -11.35M -11.11M -488M -4.56M -3.21M -2.8M -2.59M -2.43M -303M -4.58M -30.78M -11.93M -149M -12.06M -11.8M -518M
Net Debt -164K -115K -101K -93.24K -87.29K -10.9M -165K -1.11M -429K -5.36M -433K -424K -18.62M -525K -370K -323K -299K -280K -34.95M -528K -3.55M -1.38M -17.2M -1.39M -1.36M -59.74M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
26-06-22 0.2200 $ -5.38% 30,490
26-06-19 0.2325 $ +3.33% 88,770
26-06-18 0.2250 $ +2.27% 210,572
26-06-17 0.2200 $ +10.00% 648,000
26-06-16 0.2000 $ +2.56% 83,667

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!